Marshall Wace North America’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1.88M Buy
28,305
+14,185
+100% +$1.01M 0.01% 743
2021
Q2
$946K Sell
14,120
-301,548
-96% -$18.7M ﹤0.01% 1028
2021
Q1
$16.4M Buy
315,668
+135,929
+76% +$6.87M 0.07% 293
2020
Q4
$7.17M Buy
+179,739
New +$5.8M 0.03% 455
2019
Q4
Sell
-580
Closed -$13K 1598
2019
Q3
$13K Buy
+580
New +$12.4K ﹤0.01% 1251
2019
Q2
Sell
-119,786
Closed -$3.45M 1596
2019
Q1
$3.45M Buy
119,786
+70,899
+145% +$1.75M 0.02% 386
2018
Q4
$838K Buy
+48,887
New +$1.18M 0.01% 654
2017
Q2
Sell
-201,898
Closed -$3.63M 1460
2017
Q1
$3.63M Buy
+201,898
New +$3.74M 0.03% 464

Other funds holding THC

Marshall Wace North America's THC Position: Q3 2021 in Review

Marshall Wace North America increased its Tenet Healthcare (THC) stake by 100% in Q3 2021, buying an estimated $1.01M and bringing the position to 28,305 shares worth $1.88M. The position accounts for 0.01% of the portfolio, ranked #743.

Marshall Wace North America first reported a position in THC in Q1 2017 and has held it in 8 quarters since. The position peaked at $16.4M in Q1 2021. 336 funds tracked by Wall St. Rank hold THC as of Q3 2021.

  • Marshall Wace North America held 28,305 shares of Tenet Healthcare worth $1.88M as of Q3 2021.
  • Marshall Wace North America bought 14,185 Tenet Healthcare shares in Q3 2021, an estimated $1.01M.
  • Tenet Healthcare made up 0.01% of Marshall Wace North America's portfolio in Q3 2021, its #743 holding.
  • Marshall Wace North America first reported a position in Tenet Healthcare in Q1 2017 and has held it in 8 quarters since.
  • Marshall Wace North America's Tenet Healthcare position peaked at $16.4M in Q1 2021.
  • 336 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.